Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

957 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Promotion of malignant phenotype after disruption of the three-dimensional structure of cultured spheroids from colorectal cancer.
Piulats JM, Kondo J, Endo H, Ono H, Hagihara T, Okuyama H, Nishizawa Y, Tomita Y, Ohue M, Okita K, Oyama H, Bono H, Masuko T, Inoue M. Piulats JM, et al. Among authors: okita k. Oncotarget. 2018 Mar 23;9(22):15968-15983. doi: 10.18632/oncotarget.24641. eCollection 2018 Mar 23. Oncotarget. 2018. PMID: 29662620 Free PMC article.
Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role.
Yuan Q, Furukawa T, Tashiro T, Okita K, Jin ZH, Aung W, Sugyo A, Nagatsu K, Endo H, Tsuji AB, Zhang MR, Masuko T, Inoue M, Fujibayashi Y, Saga T. Yuan Q, et al. Among authors: okita k. PLoS One. 2015 Nov 16;10(11):e0143076. doi: 10.1371/journal.pone.0143076. eCollection 2015. PLoS One. 2015. PMID: 26571416 Free PMC article.
Dual-targeting therapy against HER3/MET in human colorectal cancers.
Yamasaki A, Miyake R, Hara Y, Okuno H, Imaida T, Okita K, Okazaki S, Akiyama Y, Hirotani K, Endo Y, Masuko K, Masuko T, Tomioka Y. Yamasaki A, et al. Among authors: okita k. Cancer Med. 2023 Apr;12(8):9684-9696. doi: 10.1002/cam4.5673. Epub 2023 Feb 7. Cancer Med. 2023. PMID: 36751113 Free PMC article.
CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb.
Nakano T, Okita K, Okazaki S, Yoshimoto S, Masuko S, Yagi H, Kato K, Tomioka Y, Imai K, Hamada Y, Masuko K, Shimada-Takaura K, Nagai N, Saya H, Arai T, Ishiwata T, Masuko T. Nakano T, et al. Among authors: okita k. FEBS Open Bio. 2025 Jan 5. doi: 10.1002/2211-5463.13963. Online ahead of print. FEBS Open Bio. 2025. PMID: 39757718 Free article.
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene.
Okita K, Hara Y, Okura H, Hayashi H, Sasaki Y, Masuko S, Kitadai E, Masuko K, Yoshimoto S, Hayashi N, Sugiura R, Endo Y, Okazaki S, Arai S, Yoshioka T, Matsumoto T, Makino Y, Komiyama H, Sakamoto K, Masuko T. Okita K, et al. Cancer Sci. 2021 Feb;112(2):563-574. doi: 10.1111/cas.14741. Epub 2020 Dec 11. Cancer Sci. 2021. PMID: 33211385 Free PMC article.
Structure of human Fyn kinase domain complexed with staurosporine.
Kinoshita T, Matsubara M, Ishiguro H, Okita K, Tada T. Kinoshita T, et al. Among authors: okita k. Biochem Biophys Res Commun. 2006 Aug 4;346(3):840-4. doi: 10.1016/j.bbrc.2006.05.212. Epub 2006 Jun 13. Biochem Biophys Res Commun. 2006. PMID: 16782058
Crystal structure of human mono-phosphorylated ERK1 at Tyr204.
Kinoshita T, Yoshida I, Nakae S, Okita K, Gouda M, Matsubara M, Yokota K, Ishiguro H, Tada T. Kinoshita T, et al. Among authors: okita k. Biochem Biophys Res Commun. 2008 Dec 26;377(4):1123-7. doi: 10.1016/j.bbrc.2008.10.127. Epub 2008 Nov 5. Biochem Biophys Res Commun. 2008. PMID: 18983981
957 results